Q: Hi 5i,
I read your market update with interest. You guys tend to be adders and trimmers as I am. You made a lot of incremental adds to various positions. I was surprised by the complete exit from OTEX at 4%. I believe you said on a number of times that one should not sell a good company unless there has been a fundamental change in the company, management or outlook. I do not see any fundamental change with OTEX. You said the stock has been a laggard. One always has some laggards in a portfolio. A steady eddy name can actually help you in these markets. Removing a 4% position seems out of sync with your style.
Thanks again.
P.S. Peter, great session with TD yesterday, even though I am not really a small cap guy.
Q: J's comment on March 30, about the small ADR fee charged, is interesting and I wonder if he would elaborate, e.g. how does he determine the fee, does it apply to all ADRs, etc. (This topic may be suited to the forums, if J could be redirected.)
Q: Hello. Trying to understand 2021 distributions from HCAL. According to the website the 2021 T3 distributions, per unit, was comprised of 0.07729 of eligible dividends and 3.50973 of capital gains for a total per unit distribution of 3.58702.
As it holds solely CAD banks, shouldn’t the eligible dividend portions be higher?
Q: In focusing on a sector specific purchase i guess i had my blinders on about share structure of this company! I've never been a fan of the multiple share structure model. What are your thoughts about the bought deal financing and ownership situation? Would you continue to hold?
Q: How compelling do you see it at this price, on a scale of 1 to 10 ( 10 being best).
Would you be buying here?. If not, please suggest other names you would be buying (non tech).
Thank you.
Q: Bonjour, my broker suggested an ETF with very low trading volume. But she said that the volume was actually much bigger. Is it because of in-house market or transactions between brokers that do not show on regular exchanges? Not knowing bid/ask, I’m somewhat wary of not getting a fair price for what I buy or sell. I would much prefer an ETF with some steady volume. Comments please.
I have held a balanced Canadian Couch Potato Portfolio with the above etfs in my son's RESP which i started when he was born in 2009. The portfolio has done pretty well (in my books at least) at 8% annual return. I am now looking at a 6 year time horizon for when he will need to begin to draw from the RESP. I am thinking of starting to rotate toward more conservative holdings as the timeline for needing the funds draws closer. Under "normal" circumstances from what i have learned this would mean moving more into bonds at this point but I am having trouble believing this is appropriate in the current market. With interest rates and inflation both rising i am wondering if low debt dividend stocks might be a better bet to hold onto purchasing power in this time frame? Maybe something something like CDZ vs XBB? I know you can not suggest specific portfolio recommendations but looking for suggestions/best bets for maintaining value and keeping up with inflation over this time frame.
Q: I don't know anything about technical analysis. However, looking at the chart of XBC over the past week there appear to be clear levels of support and resistance at 1.80, 1.95 and then at 2.25, Presumably this relates to investors either taking profits or exiting at a reduced loss following the recent uptick. My question: does this chart tell us anything about future levels of support or what we might expect moving forward? Thank-you for your insight.
Q: This seems to be trading at a good price lately. Their last report showed about 58 cents per share of cash flow, which translates into about 7x cash flow on an annual basis. Is this correct?
Seems like COVID and other risks are already priced in. Is debt the main concern? I note that that did come down somewhat in the last quarter.
Thx
Q: AKT.A has been showing better momentum lately, but I'm still way way down on this stock. Would you continue to hold or sell and use the funds to average down on Xebec?
My other 2 options are to either sell Knight Therapeutics, or use up some of my cash to top up Xebec.
I sold both TBRD and UNS near their lows only to watch them Rocket later, so this makes me hesitant on selling my losers, i often get it wrong.
Thanks
Q: I searched the i5 questions history and found that the last question was close to 6 months ago. I looked at the latest numbers and like that the margin % has increased and their balance sheet looks good except a for a recent large increase in inventory. Am I wrong to think they are ramping up production for unannounced orders and that the stock looks good?
Q: In a taxable well diversified account would you take a loss on SQ to buy PYPL or any other US stock in which case please make 3 suggestions. Currently hold AAPL, GOOG, CRWD, CROX. Looking for growth with medium risk. I'm a patient investor but could use some capital loss this year.
Q: I own both MAWER New Canada-MAW107 (since 2004!!) and Mawer Global Smallcap-MAW150 (since 2011) in a taxable account. Both funds declared very large capital gain distributions in 2021, much more then I experienced in the last years.. Are the capital gains really from 2021 -not the best year for MAW150 ?
I’m probably dead wrong but is it possible that after many years of good performance (let’s say 10 years), the mutual funds are required to distribute some capital gains, so that investors do not cling to them forever, and make CRA happy ?
Q: Just read an interesting Barron's article on Equinor, a Norwegian company. It appears that this company might strongly benefit from the shortages of oil and gas in Europe being so close to this market. How would you assess this company and its capacity?
Thank you!
Q: Great webinar Peter. I was pleased to hear you reinforce the ‘basket’ approach in small cap investing. Not only does it make sense, it helps one sleep much better. Thanks again.